Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)
75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
Biological Efficacy of Clopidogrel After Implantation of Drug-eluting Stents (SPACE)
Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)
Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
† Study has passed its completion date and status has not been verified in more than two years.